Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SCO-240 by Scohia Pharma for Growth Hormone Deficiency: Likelihood of Approval
SCO-240 is under clinical development by Scohia Pharma and currently in Phase I for Growth Hormone Deficiency. According to GlobalData,...
Data Insights
SCO-240 by Scohia Pharma for Cholelithiasis: Likelihood of Approval
SCO-240 is under clinical development by Scohia Pharma and currently in Phase I for Cholelithiasis. According to GlobalData, Phase I...